• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国东南部地区乙型肝炎的流行情况:一项基于大样本的人群研究。

Prevalence of hepatitis B in the southeast of China: a population-based study with a large sample size.

机构信息

State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, People's Republic of China.

出版信息

Eur J Gastroenterol Hepatol. 2011 Aug;23(8):695-700. doi: 10.1097/MEG.0b013e328347322b.

DOI:10.1097/MEG.0b013e328347322b
PMID:21617533
Abstract

OBJECTIVE

Hepatitis B is a major public health problem in China. However, in the past 10 years, estimates of the prevalence of hepatitis B virus (HBV) have been sparse, with results that do not always agree. The purpose of this study was to investigate the epidemiology of HBV in adults and to provide the most recent baseline data for planning and monitoring of health.

METHODS

The prevalence of HBV was determined in a community-based, cross-sectional, age-stratified sample of adults (aged 20 years or older). The study population was selected using random multistage cluster sampling. Demographic information and serological samples were obtained from 19 933 participants.

RESULTS

The prevalence of anti-HBV core antibody, HBV surface antigen (HBsAg), and anti-HBV surface antibody was 38.6, 7.9, and 44.9%, respectively. We found statistically significant differences in hepatitis B infection between men and women (P<0.001). The prevalence of HBV infection increased with age. The rates of HBsAg positivity and HBV infection in individuals living on an island were higher than those of individuals living in plains. The alanine aminotransferase level was elevated (≥38 IU/l) in 15.7 and 7.2% of HBsAg-positive and HBsAg-negative patients; the proportion of elevated alanine aminotransferase was markedly higher in men (12.7%) than in women (4.7%) (P<0.001). The α-fetoprotein-positive rate was 2% in HBsAg-positive individuals who were aged 30 years or older.

CONCLUSION

Borderline intermediate/high endemicity was found among adults in the northern region of Zhejiang Province. The vaccination program has contributed to a reduction in infection over the last 20 years, although further efforts are required to turn the region into a 'low-endemicity' area.

摘要

目的

乙型肝炎是中国的一个主要公共卫生问题。然而,在过去的 10 年中,乙型肝炎病毒(HBV)流行率的估计值很少,结果并不总是一致的。本研究的目的是调查成人乙型肝炎病毒的流行病学情况,为规划和监测健康提供最新的基线数据。

方法

采用基于社区的、横断面、年龄分层的成年人(年龄在 20 岁或以上)样本,确定 HBV 的流行率。使用随机多级聚类抽样选择研究人群。从 19933 名参与者中获得人口统计学信息和血清学样本。

结果

抗 HBV 核心抗体、HBV 表面抗原(HBsAg)和抗 HBV 表面抗体的流行率分别为 38.6%、7.9%和 44.9%。我们发现男女之间的乙型肝炎感染存在统计学上的显著差异(P<0.001)。HBV 感染的流行率随年龄增长而增加。居住在岛屿上的个体的 HBsAg 阳性率和 HBV 感染率高于居住在平原上的个体。丙氨酸氨基转移酶水平升高(≥38IU/L)的 HBsAg 阳性和 HBsAg 阴性患者分别为 15.7%和 7.2%;男性(12.7%)的丙氨酸氨基转移酶水平升高比例明显高于女性(4.7%)(P<0.001)。年龄在 30 岁或以上的 HBsAg 阳性个体中,甲胎蛋白阳性率为 2%。

结论

在浙江省北部地区的成年人中发现了边缘中度/高度流行。过去 20 年来,疫苗接种计划已有助于减少感染,但仍需要进一步努力将该地区转变为“低流行区”。

相似文献

1
Prevalence of hepatitis B in the southeast of China: a population-based study with a large sample size.中国东南部地区乙型肝炎的流行情况:一项基于大样本的人群研究。
Eur J Gastroenterol Hepatol. 2011 Aug;23(8):695-700. doi: 10.1097/MEG.0b013e328347322b.
2
Markers of hepatitis B infection in Tari District, Southern Highlands Province, Papua New Guinea.巴布亚新几内亚南部高地省塔里地区的乙型肝炎感染标志物。
P N G Med J. 1992 Sep;35(3):197-201.
3
Seroepidemiology of hepatitis B, delta and human immunodeficiency virus infections in Hamadan province, Iran: a population based study.伊朗哈马丹省乙型肝炎、丁型肝炎和人类免疫缺陷病毒感染的血清流行病学:一项基于人群的研究。
J Trop Med Hyg. 1993 Oct;96(5):277-87.
4
Hepatitis B virus infection and hepatocellular carcinoma among parous Taiwanese women: nationwide cohort study.台湾已育女性中的乙型肝炎病毒感染与肝细胞癌:全国性队列研究
J Natl Cancer Inst. 2009 Jul 15;101(14):1019-27. doi: 10.1093/jnci/djp146. Epub 2009 Jun 17.
5
Clinical features of HBsAg-negative but anti-HBc-positive hepatocellular carcinoma in a hepatitis B virus endemic area.乙肝病毒流行地区HBsAg阴性但抗-HBc阳性的肝细胞癌的临床特征
J Gastroenterol Hepatol. 2005 May;20(5):746-51. doi: 10.1111/j.1440-1746.2005.03747.x.
6
Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.隐匿性乙型肝炎病毒感染和既往乙型肝炎病毒感染对丙型肝炎病毒所致肝硬化患者肝细胞癌发生的影响
Scand J Gastroenterol. 2008;43(7):849-56. doi: 10.1080/00365520801935459.
7
De novo hepatitis B after liver transplantation from hepatitis B core antibody-positive donors in an area with high prevalence of anti-HBc positivity in the donor population.在供体人群中抗-HBc阳性率较高的地区,接受来自乙肝核心抗体阳性供体的肝移植后发生的新发乙型肝炎。
Liver Transpl. 2001 Jan;7(1):51-8. doi: 10.1053/jlts.2001.20786.
8
The prevalence of occult hepatitis B virus infection in type 2 diabetes mellitus patients.2型糖尿病患者中隐匿性乙型肝炎病毒感染的患病率
Eur J Gastroenterol Hepatol. 2008 Jul;20(7):668-73. doi: 10.1097/MEG.0b013e3282f55e1e.
9
The decline of hepatitis B viral infection in South-Western Saudi Arabia.沙特阿拉伯西南部乙型肝炎病毒感染率的下降。
Saudi Med J. 2003 Sep;24(9):991-5.
10
Prevalence of hepatitis B virus markers among blood donors in a tertiary hospital in Tabuk, northwestern Saudi Arabia.沙特阿拉伯西北部塔布克一家三级医院献血者中乙肝病毒标志物的流行情况。
Int J Infect Dis. 2008 Sep;12(5):495-9. doi: 10.1016/j.ijid.2008.01.010. Epub 2008 Apr 8.

引用本文的文献

1
Risk of Hepatitis B Virus Reactivation in Patients with Resolved Infection on Therapy with Corticosteroids and Conventional Synthesis Immunosuppressants for Kidney Disease: A Single-Center Analysis of 258 Patients.接受皮质类固醇和常规合成免疫抑制剂治疗的肾病患者中已解决感染患者乙型肝炎病毒再激活的风险:单中心 258 例患者分析。
Turk J Gastroenterol. 2023 Oct;34(10):1035-1040. doi: 10.5152/tjg.2023.22511.
2
Hepatitis B Virus Chronic Infection in Blood Donors from Asian and African High or Medium Prevalence Areas: Comparison According to Sex.亚洲和非洲高或中度流行地区献血者中的乙型肝炎病毒慢性感染:按性别比较。
Viruses. 2022 Mar 24;14(4):673. doi: 10.3390/v14040673.
3
The effect of hepatitis B vaccination after five years on an entire population in an insular region of Southeast China.
中国东南岛屿地区人群乙型肝炎疫苗接种 5 年后的效果。
Hum Vaccin Immunother. 2021 May 4;17(5):1530-1535. doi: 10.1080/21645515.2020.1814096. Epub 2020 Dec 14.
4
Estimating the proportion of people with chronic hepatitis B virus infection eligible for hepatitis B antiviral treatment worldwide: a systematic review and meta-analysis.全球范围内符合乙型肝炎抗病毒治疗条件的慢性乙型肝炎病毒感染者比例估计:一项系统评价和荟萃分析。
Lancet Gastroenterol Hepatol. 2021 Feb;6(2):106-119. doi: 10.1016/S2468-1253(20)30307-1. Epub 2020 Nov 14.
5
The hepatitis B core antibody positive/hepatitis B surface antigen negative pattern is associated with the increased risk of intracranial atherosclerotic stenosis.乙肝核心抗体阳性/乙肝表面抗原阴性模式与颅内动脉粥样硬化性狭窄风险增加相关。
Medicine (Baltimore). 2020 Jan;99(2):e18752. doi: 10.1097/MD.0000000000018752.
6
Analysis of Hepatitis B Virus Reactivation After Radiotherapy in Patients With Hepatocellular Carcinoma Using the Lyman NTCP Model.应用 Lyman NTCP 模型分析肝细胞癌患者放疗后乙型肝炎病毒再激活。
Technol Cancer Res Treat. 2019 Jan 1;18:1533033819875136. doi: 10.1177/1533033819875136.
7
Development and initial validation of the chronic hepatitis B quality of life instrument (CHBQOL) among Chinese patients.开发并初步验证了适用于中国患者的慢性乙型肝炎生活质量量表(CHBQOL)。
Qual Life Res. 2019 Nov;28(11):3071-3081. doi: 10.1007/s11136-019-02240-7. Epub 2019 Jun 26.
8
Increased risk of hepatitis B virus infection amongst individuals with diabetes mellitus.糖尿病患者乙型肝炎病毒感染风险增加。
Biosci Rep. 2019 Mar 28;39(3). doi: 10.1042/BSR20181715. Print 2019 Mar 29.
9
Effects of transarterial chemoembolization combined with antiviral therapy on HBV reactivation and liver function in HBV-related hepatocellular carcinoma patients with HBV-DNA negative.经动脉化疗栓塞联合抗病毒治疗对HBV-DNA阴性的HBV相关肝细胞癌患者HBV再激活及肝功能的影响
Medicine (Baltimore). 2018 Jun;97(22):e10940. doi: 10.1097/MD.0000000000010940.
10
Socioeconomic inequality in Hepatitis B vaccination of rural adults in China.中国农村成年人乙型肝炎疫苗接种的社会经济不平等。
Hum Vaccin Immunother. 2018 Feb 1;14(2):464-470. doi: 10.1080/21645515.2017.1396401. Epub 2017 Dec 6.